|
1. Jaffe RI, Lane JD, Bates CW. Real‐time identification of Pseudomonas aeruginosa direct from clinical samples using a rapid extraction method and polymerase chain reaction (PCR). J Clin Lab Anal 2001; 15:131-7. doi: 10.1002/jcla.1016. 2. Qin X, Emerson J, Stapp J, Stapp L, Abe P, Burns JL. Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis. J Clin Microbiol 2003; 41:4312-7. doi: 10.1128/JCM.41.9.4312-4317.2003. 3. Drenkard E, Ausubel FM. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 2002;416: 740-3. doi: 10.1038/416740a. 4. Rather MA, Gupta K, Mandal M. Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies. Braz J Microbiol 2021; 52:1701-18. doi: 10.1007/s42770-021-00624-x. 5. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999; 43:1379-82. doi: 10.1128/AAC.43.6.1379. 6. Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 2007; 67:351-68. doi: 10.2165/00003495-200767030-00003. 7. 7. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res 2003; 2:48-62. 8. 8. Begum S, Salam MA, Alam KF, Begum N, Hassan P, Haq JA. Detection of extended spectrum β-lactamase in Pseudomonas spp. isolated from two tertiary care hospitals in Bangladesh. BMC Res Notes 2013:6:7. doi: 10.1186/1756-0500-6-7. 9. Salimi F, Eftekhar F. Prevalence of blAbstractP and blaVIM gene carriage in metallo-beta-lactamase-producing burn isolates of Pseudomonas aeruginosa in Tehran.Turk J Med Sci 2014;44:511-4. doi: 10.3906/sag-1302-67. 10. PA W. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI document M100-S20. 2010. 11. Bahador N, Shoja S, Faridi F, Dozandeh-Mobarrez B, Qeshmi FI, Javadpour S, et al. Molecular detection of virulence factors and biofilm formation in Pseudomonas aeruginosa obtained from different clinical specimens in Bandar Abbas. Iran J Microbiol 2019; 11:25-30. 12. Queipo-Ortuño MI, De Dios Colmenero J, Macias M, Bravo MJ, Morata P. Preparation of bacterial DNA template by boiling and effect of immunoglobulin G as an inhibitor in real-time PCR for serum samples from patients with brucellosis. Clin Vaccine Immunol 2008; 15:293-6. doi: 10.1128/CVI.00270-07. 13. Kazemian H, Heidari H, Ghanavati R, Ghafourian S, Yazdani F, Sadeghifard N, et al. Phenotypic and genotypic characterization of ESBL-, AmpC-, and carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates. Med Princ Pract 2019; 28:547-51. doi: 10.1159/000500311. 14. Ratajczak M, Kamińska D, Nowak-Malczewska DM, Schneider A, Dlugaszewska J. Relationship between antibiotic resistance, biofilm formation, genes coding virulence factors and source of origin of Pseudomonas aeruginosa clinical strains. Ann Agric Environ Med 2021; 28:306-13. doi: 10.26444/aaem/122682. 15. Sader HS, Carvalhaes CG, Streit JM, Doyle TB, Castanheira M. Antimicrobial activity of ceftazidime-avibactam, ceftolozane-tazobactam and comparators tested against Pseudomonas aeruginosa and Klebsiella pneumoniae isolates from United States Medical Centers in 2016-2018. Microb Drug Resist 2021; 27:342-49. doi: 10.1089/mdr.2020.0217. 16. Fazeli H, Moslehi Z, Irajian G, Salehi M. Determination of Drug resistance patterns and detection of bla-VIM gene in Pseudomonas aeruginosastrains Isolated from burned patients in the Emam Mosa Kazem hospital, Esfahan, Iran (2008-9). Iran J Med Microbiol 2010; 3:1-8. 17. Bhatt P, Rathi KR, Hazra S, Sharma A, Shete V. Prevalence of multidrug resistant Pseudomonas aeruginosa infection in burn patients at a tertiary care centre. Burns 2015; 23:56-9. 18. Senthamarai S, Sivasankari S, Anitha C, Somasunder V, Kumudhavathi M, Amshavathani S, et al. Resistance pattern of Pseudomonas aeruginosa in a tertiary care hospital of Kanchipuram, Tamilnadu, India. Clin Diagn Res 2014;8: DC30-2. doi: 10.7860/JCDR/2014/7953.4388. 19. Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum β-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns 2010; 36:70-4. doi: 10.1016/j.burns.2009.01.015. 20. Imani Foolad A, Hosainzadeh M, Mousavi SF. Association between exotoxin A (exo-A) gene and antibiotic resistance pattern with biofilm formation in Pseudomonas aeruginosa. J Ardabil Univ Med Sci 2011; 11:7-13. 21. da Silva Carvalho T, Perez LRR. Impact of biofilm production on polymyxin B susceptibility among Pseudomonas aeruginosa clinical isolates. Infect Control Hosp Epidemiol 2019; 40:739-40. doi: 10.1017/ice.2019.85. 22. Lima JLdC, Alves LR, Jacomé PRLdA, Bezerra Neto JP, Maciel MAV, Morais MMCd. Biofilm production by clinical isolates of Pseudomonas aeruginosa and structural changes in LasR protein of isolates non-biofilm-producing. Braz J Infect Dis 2018; 22:129-36. doi: 10.1016/j.bjid.2018.03.003. 23. Memar MY, Adibkia K, Farajnia S, Kafil HS, Khalili Y, Azargun R, et al. In-vitro effect of imipenem, fosfomycin, colistin, and gentamicin combination against carbapenem-resistant and biofilm-forming Pseudomonas aeruginosa isolated from burn patients. Iran J Pharm Res 2021; 20:286-96. doi: 10.22037/ijpr.2020.
|
